Golimumab effectiveness and safety in clinical practice for moderately active ulcerative colitis.
O'Connell J, Rowan C, Stack R, Harkin G, Parihar V, Chan G, Breslin N, Cullen G, Dunne C, Egan L, Harewood G, Leyden J, MacCarthy F, MacMathuna P, Mahmud N, McKiernan S, McNamara D, Mulcahy H, Murray F, O'Connor A, O'Toole A, Patchett S, Ryan B, Sheridan J, Slattery E, Doherty G, Kevans D.
O'Connell J, et al.
Eur J Gastroenterol Hepatol. 2018 Sep;30(9):1019-1026. doi: 10.1097/MEG.0000000000001177.
Eur J Gastroenterol Hepatol. 2018.
PMID: 29878945